Angiotensin Receptor Blockers (ARBs) Global Market 2024 To Reach $10.28 Billion By 2028 At Rate Of 4.5%

Angiotensin Receptor Blockers (ARBs) Global Market Size, Insights Forecast, Growth, Trends 2024-2033

LONDON, GREATER LONDON, UNITED KINGDOM, October 1, 2024 /EINPresswire.com/ -- The angiotensin receptor blockers (ARBs) market has experienced robust growth in recent years, expanding from $8.26 billion in 2023 to $8.62 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to hypertension epidemic, clinical efficacy, cardiovascular disease burden, renal protection, clinical guidelines, ARBs as first-line treatment, cost-effectiveness.

What Is The Estimated Market Size Of The Global Angiotensin Receptor Blockers (ARBs) Market And Its Annual Growth Rate?
The angiotensin receptor blockers (ARBs) market is projected to continue its strong growth, reaching $10.28 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to precision medicine approaches, focus on combination therapies, global expansion of market, biomarker-based treatment strategies, government initiatives, increased awareness of hypertension.

Explore Comprehensive Insights Into The Global Angiotensin Receptor Blockers (ARBs) Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=8943&type=smp

Growth Driver Of The Angiotensin Receptor Blockers (ARBs) Market
The increasing chronic kidney diseases is expected to propel the growth of the angiotensin receptor blockers market going forward. Chronic kidney disease (CKD) is a long-term condition characterized by the gradual loss of kidney function over time. Angiotensin receptor blockers (ARBs) are used in the management of chronic kidney diseases (CKD) by lowering blood pressure, provide renal protection, to manage diabetic nephropathy, and in cardiovascular complications.

Make Your Report Purchase Here And Explore The Whole Industry's Data As Well:
https://www.thebusinessresearchcompany.com/report/angiotensin-receptor-blockers-arbs-global-market-report

Who Are the Leading Competitors in the Angiotensin Receptor Blockers (ARBs) Market Share?
Key players in the market include Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Movianto, Clinical Trial Logistics, Thermo Fisher Scientific, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, Abbvie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma.

Which Key Trends Are Driving Angiotensin Receptor Blockers (ARBs) Market Growth?
Major market players operating on angiotensin receptor blockers (ARBs) market are concentrating their efforts on creating innovative products and getting its approvals to strengthen their position in the market. Vericiguat is a medication used in the treatment of heart failure. It is a soluble guanylate cyclase (sGC) stimulator, and it is indicated to reduce the risk of cardiovascular death.

How Is The Global Angiotensin Receptor Blockers (ARBs) Market Segmented?
1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers

Geographical Insights: North America Leading The Angiotensin Receptor Blockers (ARBs) Market
North America was the largest region in the market in 2023. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Angiotensin Receptor Blockers (ARBs) Market Definition
Angiotensin receptor blockers (ARBs) are medications that dilate (widen) blood vessels and are used to treat conditions such as high blood pressure (hypertension), heart failure, and kidney disease in people with diabetes. Angiotensin is a chemical in the body that causes blood vessels to constrict. This constriction can raise the blood pressure and make the heart work harder.

Angiotensin Receptor Blockers (ARBs) Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Macroeconomic factors affecting the market in the short and long run
• Analysis of the macro and micro economic factors that have affected the market in the past five years
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

An overview of the global angiotensin receptor blockers (ARBs) market report covering trends, opportunities, strategies, and more
The Angiotensin Receptor Blockers (ARBs) Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on angiotensin receptor blockers (ARBs) market size, angiotensin receptor blockers (ARBs) market drivers and trends, angiotensin receptor blockers (ARBs) market major players and angiotensin receptor blockers (ARBs) market growth across geographies. This report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Convalescent Plasma Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Mycoplasma Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Patient Blood Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

What Does The Business Research Company Do?
The Business Research Company publishes over 15,000 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package, and much more.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn